Dynamic history of low-grade gliomas before and after temozolomide treatment-Reference-Cited by-同舟云学术

Dynamic history of low-grade gliomas before and after temozolomide treatment

Published:2007 Issue:5 Volume:61 Page:484-490
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Ricard Damien,Kaloshi Gentian,Amiel-Benouaich Alexandra,Lejeune Julie,Marie Yannick,Mandonnet Emmanuel,Kujas Michèle,Mokhtari Karima,Taillibert Sophie,Laigle-Donadey Florence,Carpentier Antoine F.,Omuro Antonio,Capelle Laurent,Duffau Hugues,Cornu Philippe,Guillevin Rémy,Sanson Marc,Hoang-Xuan Khê,Delattre Jean-Yves

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference10 articles.

1. Continuous growth of mean tumor diameter in a subset of grade II gliomas

2. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion

3. Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

4. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

5. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review;Clinical Pharmacokinetics;2024-08-17

2. Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma;International Journal of Radiation Oncology*Biology*Physics;2024-02

3. Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion;Neurosurgical Focus;2024-02

4. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma—Letter;Clinical Cancer Research;2024-02-01

5. Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma—Response;Clinical Cancer Research;2024-02-01